Literature DB >> 8501536

Expression of the nuclear membrane protein statin in cycling cells.

B Ansari1, R Dover, C P Gillmore, P A Hall.   

Abstract

Statin is a 57 kD protein previously reported to be expressed by cells in G0. We have studied the detailed distribution of statin immunoreactivity in normal human and rat tissues, and correlated this with investigation of in vitro model systems. By laser confocal microscopy, statin immunoreactivity is localized to the nuclear membrane. In contrast to previous reports, using in vitro model systems we found that statin was also expressed by replicating cells as judged by both co-localization with [3H]thymidine-labelled and Ki67-labelled cells. Furthermore, in a nude mouse xenograft model the number of statin-labelled cells exceeded the number of quiescent cells as assessed by both fraction of labelled mitosis methods and labelling with [3H]thymidine and Ki67. We conclude that although there is an association between expression of the 57 kD nuclear membrane protein statin and growth arrest, this is not absolute and it is expressed in a sub-population of cycling cells. The properties of statin closely resemble those of nuclear lamins, members of the intermediate filament family.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8501536     DOI: 10.1002/path.1711690402

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  2 in total

Review 1.  Transcriptional reprogramming in cellular quiescence.

Authors:  Benjamin Roche; Benoit Arcangioli; Robert Martienssen
Journal:  RNA Biol       Date:  2017-05-12       Impact factor: 4.652

2.  p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival.

Authors:  M Barbareschi; O Caffo; C Doglioni; P Fina; A Marchetti; F Buttitta; R Leek; L Morelli; E Leonardi; G Bevilacqua; P Dalla Palma; A L Harris
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.